Blue Owl Capital, a major alternative asset manager, is deepening its push into the insurance sector, but it plans to do so without actually buying an insurance company. Co-CEO Doug Ostrover said the firm will grow by running insurers' investment portfolios for a fee, a strategy he described as “balance-sheet-light.”
Speaking at a Financial Times and Latham & Watkins conference in London, Ostrover outlined the approach, which the Financial Times reported on Wednesday. Instead of taking on the regulatory capital and policy liabilities that come with owning an insurer, Blue Owl wants to manage insurance assets on behalf of other companies, collecting management and performance fees in the process.
What is a ‘balance-sheet-light’ model?
In the world of asset management, there are two broad ways to tap into insurance money. One is to buy an insurer outright. That gives the buyer a permanent pool of capital—the premiums policyholders pay—but it also brings heavy baggage: insurance regulators, reserving requirements, and the risk that underwriting losses eat into returns.
The other way is to manage the investment portfolios of existing insurers. That is the route Blue Owl is choosing. By acting as an investment manager rather than an owner, the firm avoids the regulatory capital that insurers must hold against their liabilities. It also sidesteps the “spread” business, where profits depend on the difference between what insurers earn on investments and what they pay out in claims.
Instead, Blue Owl’s insurance growth will look more like traditional asset management: winning mandates, growing assets under management, and earning fees. The company has also hired insurance executive Deva Mishra to help shape the strategy, according to the Financial Times.
Why insurers are attractive to asset managers
Insurance companies sit on vast pools of long-dated capital. That money is often invested in bonds, private credit, real estate, and other assets that can generate steady, predictable returns. For an asset manager like Blue Owl, managing that money is a way to secure long-term, sticky capital without the complexity of running an insurance operation.
The strategy is not unique to Blue Owl. Several large private equity and asset management firms have been building insurance platforms in recent years, either by buying insurers or by partnering with them. The appeal is clear: insurance money is patient and less likely to flee during market downturns, which can help stabilise an asset manager’s revenue.
But the structure matters. Buying an insurer can create very durable funding, yet it also brings leverage constraints, reserving risk, and tight oversight from insurance regulators. Blue Owl is signalling it would rather keep its own balance sheet cleaner and earn fees by managing other insurers’ assets.
What it means for investors
For investors, the key takeaway is that Blue Owl’s insurance push will show up in fee-related earnings, not in underwriting results. That means the firm’s performance will be tied to its ability to win and retain mandates, rather than to the insurance cycle.
That has both upsides and downsides. On the plus side, a fee-based model is generally less capital-intensive and can be more predictable than an insurer’s spread business. It also avoids the risk of catastrophic claims or reserve shortfalls. On the downside, fee-based revenue is exposed to competition, pricing pressure, and the risk that clients take their business elsewhere when contracts come up for renewal.
Investors often lump “insurance” strategies together, but the structure matters. A balance-sheet-light approach may appeal to shareholders who prefer cleaner earnings and lower regulatory risk. However, it also means Blue Owl will need to keep winning mandates to grow, and that growth could be more sensitive to market conditions than a traditional insurer’s would be.
The broader backdrop is also worth noting. Alternative asset managers have been under pressure to find new sources of growth as traditional fundraising slows. Insurance capital offers a relatively stable base, and Blue Owl’s move is part of a wider trend. But the firm’s decision to avoid buying an insurer suggests it values flexibility and a clean balance sheet over the potential benefits of owning an insurance company.
For everyday investors, the story is a reminder that not all “insurance” investments are the same. When a company says it is expanding into insurance, it is worth asking whether it is taking on underwriting risk or simply managing assets for a fee. Blue Owl is clearly choosing the latter, and that will shape how its results look in the quarters ahead.
